Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Peptide Library / Detail
Half-life
~45–60 minutes (SC); pharmacodynamic effects ~2–3 hours
Delivery
Subcutaneous injection immediately prior to major meals (separate site from insulin).
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
Pramlintide is a synthetic analog of human amylin, a beta-cell co-secreted peptide with insulin. In research settings it’s used to study postprandial glucose control, gastric emptying, satiety, and glucagon suppression.
Investigated as an adjunct to mealtime insulin to model reductions in postprandial hyperglycemia and appetite, and to explore amylin physiology in metabolic studies.
Activates amylin receptors to slow gastric emptying, suppress inappropriate postprandial glucagon secretion, and enhance satiety—thereby reducing postprandial glucose excursions.
Pramlintide is a synthetic analog of human amylin, a beta-cell co-secreted peptide with insulin. In research settings it’s used to study postprandial glucose control, gastric emptying, satiety, and glucagon suppression.
Pramlintide has an approximate half-life of ~45–60 minutes (SC); pharmacodynamic effects ~2–3 hours. The half-life determines how often you need to inject to maintain steady blood levels — use the Peptides Calculator half-life calculator to plot your specific dosing schedule and see the decay curve.
Pramlintide is typically delivered via subcutaneous injection immediately prior to major meals (separate site from insulin).. The Peptides Calculator app helps you reconstitute the vial with bacteriostatic water, calculate your exact dose in syringe units, and track each injection.
Activates amylin receptors to slow gastric emptying, suppress inappropriate postprandial glucagon secretion, and enhance satiety—thereby reducing postprandial glucose excursions.
Studied benefits of Pramlintide include: Reduces postprandial glucose excursions, Decreases glucagon surge after meals, Slows gastric emptying, May reduce appetite and caloric intake. These are research findings only — Peptides Calculator does not provide medical advice; consult a qualified healthcare professional before starting any peptide protocol.
Reported side effects of Pramlintide include: Nausea, vomiting, abdominal discomfort, Decreased appetite, Injection-site reactions, Hypoglycemia when used with insulin (requires mealtime insulin dose reduction), Boxed warning: severe insulin-induced hypoglycemia risk, especially within 3 hours post-dose. Always discuss potential side effects with a licensed healthcare provider before using any research peptide.